Talk:Breast cancer treatment

This MedLibrary.org supplementary page on Talk:Breast cancer treatment is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

This is the talk page for discussing improvements to the Breast cancer treatment article.

Article policies
 
This article is within the scope of the following WikiProjects:
To-do list for Breast cancer treatment:

Here are some tasks you can do:

    Possibly copyright violation

    I just barely split article out from main Breast cancer page. I will scan the article and try to rewrite/paraphrase where possible to avoid copy violation. Consider this a hang on tag for a couple hours until I can do this. Optigan13 05:51, 13 October 2007 (UTC)

    You don't have to rewrite it, since the source is Wikipedia. You just have to attribute the parent article for GFDL compliance reasons. I'll do it below and on the article page. -- But|seriously|folks  05:53, 13 October 2007 (UTC)

    Attribution

    • The original version of this article incorporated text from the Wikipedia article Breast cancer. -- But|seriously|folks  05:53, 13 October 2007 (UTC)

    LN as indication for XRT

    I changed the XRT section from "4 or more LNs" (paraphrasing here) as an indication for post-mastectomy XRT (PMRT) to "substantial involvement" as an indication. The 4 or more recommendation is predominantly based on subset analysis from the randomized Danish PMRT studies. Similar subset analyses demonstrate that the 1-3 positive LN patients have the same relative survival benefit as those with greater numbers of LNs, even with 8 or more nodes removed (median in the study was 7 LN removed, and this has formed the basis for the argument that fewer LNs involved probably do not require PMRT if "adequate" surgery (10 or more nodes) is performed). Three randomized studies have shown a survival benefit for PMRT in node positive patients, while one has not. Thus, the NCCN advocates PMRT for all women with 4 or more nodes involved and "strong consideration" for women with 1-3 nodes involved. I feel the new wording is more permissive in allowing consideration of PMRT in all node positive patients (micromets or IHC excluded, hence the "substantial" wording) rather than just in those women with 4 or more positive nodes. Schwartzenator (talk) 04:47, 20 May 2008 (UTC)

    Wikipedia content modification information:

    • This page was last modified on 20 May 2008, at 04:47.

    Wikipedia Authorship and Review

    Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

    Wikipedia Usage Guidelines

    This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Talk:Breast cancer treatment".

    The URL for this specific entry is:

    All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.